ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing
Launched by JOHNS HOPKINS UNIVERSITY · Dec 5, 2018
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new, quick test for Hepatitis C (HCV) that can provide results in just one hour using a simple finger-stick sample. Hepatitis C is a serious virus that can lead to severe health problems if not treated. Many people with the virus don’t know they are infected because the traditional tests take longer and require specialized lab work. In this study, researchers want to find out how well patients in the emergency department understand and accept this new test compared to the standard method, which takes 1-2 days for results.
To participate in the trial, you must be at least 18 years old, have a positive test for HCV antibodies but not have had your virus level tested yet, and be able to give informed consent. If you join, you'll be randomly assigned to either receive the new quick test or the standard test. Everyone will complete a short survey about their care and treatment. The results from the quick test will be available in about two hours, while the standard test results will come later. This study aims to improve how we diagnose and treat Hepatitis C, making it easier for patients to get the care they need.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any Johns Hopkins Emergency Department patient who has HCV antibody positive result but no HCV RNA test result in the chart
- • Able to provide informed consent
- • 18-100 years
- Exclusion Criteria:
- • Patient who has a diagnosis of chronic HCV infection
- • Patient with a non-reactive test result of an HCV Ab screening test
- • Patient with a chief complaint of sexual assault
- • Patients who are otherwise ineligible to consent due to medical condition (e.g., severe illness, altered mental status)
- • Any person who has previously enrolled in this study
- • Any person less than 18 years of age
- • Any person who is incarcerated
- • Any woman who is pregnant
- • Any person who is transgender
- • Any person who is sex worker
- • Any person who is refugee
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Yu-Hsiang Hsieh, PhD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials